Reviews on Recent Clinical Trials
Title:Meet Our Editorial Board Member:
Volume: 10 Issue: 4
Author(s): Ryszard M. Pluta
Affiliation:
Export Options
About this article
Cite this article as:
M. Pluta Ryszard, Meet Our Editorial Board Member:, Reviews on Recent Clinical Trials 2015; 10 (4) . https://dx.doi.org/10.2174/157488711004151028095136
DOI https://dx.doi.org/10.2174/157488711004151028095136 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
18
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MicroRNA-10b Induces Vascular Muscle Cell Proliferation Through Akt Pathway by Targeting TIP30
Current Vascular Pharmacology Sepsis, Coagulation and Anticoagulants
Endocrine, Metabolic & Immune Disorders - Drug Targets Current and Future Treatment Options in Idiopathic Pulmonary Fibrosis
Inflammation & Allergy - Drug Targets (Discontinued) Therapeutic Progress and Knowledge Basis on the Natriuretic Peptide System in Heart Failure
Current Topics in Medicinal Chemistry Recent Advances in Endocrine Metabolic Immune Disorders Drug Targeting: An Editorial Overview
Endocrine, Metabolic & Immune Disorders - Drug Targets Metalloporphyrins-Catalyzed Synthesis of 2-Carboxybenzothiazole from 2-Methylbenzothiazole Using Molecular Oxygen as Oxidant
Current Organocatalysis New Trends in Biological Activities and Clinical Studies of Quinolinic Analogues: A Review
Current Drug Targets A Blood Vessel Deformation Model Based Virtual-reality Simulator for the Robotic Catheter Operating System
Neuroscience and Biomedical Engineering (Discontinued) The Etiology of Hypertension in the Metabolic Syndrome Part Three: The Regulation and Dysregulation of Blood Pressure
Current Vascular Pharmacology Cardiovascular Complications in Diabetes: Lessons from Animal Models
Current Medicinal Chemistry Substance-Related Disorders and Somatic Symptoms: How Should Clinicians Understand the Associations?
Current Drug Abuse Reviews Symptomatic Improvement, Increased Life-Span and Sustained Cell Homing in Amyotrophic Lateral Sclerosis After Transplantation of Human Umbilical Cord Blood Cells Genetically Modified with Adeno-Viral Vectors Expressing a Neuro-Protective Factor and a Neural Cell Adhesion Molecule
Current Gene Therapy Systemic Sclerosis-Related Pulmonary Hypertension: Unique Characteristics and Future Treatment Targets
Current Pharmaceutical Design Neuroinflammatory Markers in Spontaneously Hypertensive Rat Brain: An Immunohistochemical Study
CNS & Neurological Disorders - Drug Targets Mutations of Mitochondrial DNA in Atherosclerosis and Atherosclerosis-Related Diseases
Current Pharmaceutical Design Editorial (Thematic Issue: Modifying Cardiovascular Risk Factors: Newer Advances in Cardiovascular Metabolism and Diagnostic Technologies)
Current Pharmaceutical Design Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases
Current Pharmaceutical Design PPARs and Diabetes-Associated Atherosclerosis
Current Pharmaceutical Design Is There An Association Between Vitamin D and Hypertension?
Recent Patents on Cardiovascular Drug Discovery Human Urotensin II and Metabolic Syndrome
Vascular Disease Prevention (Discontinued)